Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 3284 entries
View as:

Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response

Phase: N/A Priority: Normal
NCT ID: NCT00392002 Org: User:
Start: 10/31/05 End: 05/31/07 Due: 05/31/08

Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®)

Phase: N/A Priority: Normal
NCT ID: NCT02859129 Org: User:
Start: 09/30/13 End: 11/30/13 Due: 11/30/14

Symbicort SMART (Symbicort Maintenance And Reliever Therapy)

Phase: N/A Priority: Normal
NCT ID: NCT00523679 Org: User:
Start: 07/31/07 End: 07/31/08 Due: 07/31/09

Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00657904 Org: User:
Start: 08/31/95 End: 08/31/08 Due: 08/31/09

Observational Retrospective Study To Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab in the Framework Of Use in Special Situations Prior to Commercialisation in Spain

Phase: N/A Priority: Normal
NCT ID: NCT06487065 Org: User:
Start: 06/17/24 End: 10/25/24 Due: 10/25/25

Bioavailability of AZD0284 and IV Microtracer Study

Phase: N/A Priority: Normal
NCT ID: NCT03029741 Org: User:
Start: 02/21/17 End: 03/23/17 Due: 03/23/18

An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants

Phase: N/A Priority: Normal
NCT ID: NCT02273882 Org: User:
Start: 11/17/14 End: 08/19/16 Due: 08/19/17

Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients

Phase: N/A Priority: Normal
NCT ID: NCT00931320 Org: User:
Start: 07/31/09 End: 09/30/09 Due: 09/30/10

Arimidex Observational: Reason for and Effect of Change From Tamoxifen

Phase: N/A Priority: Normal
NCT ID: NCT00246961 Org: User:
Start: 07/31/04 End: - Due: -

A Phase I PK Study of Balcinrenone/Dapagliflozin in Healthy Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT06651021 Org: User:
Start: 10/21/24 End: 10/28/24 Due: 10/28/25

Study to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer).

Phase: N/A Priority: Normal
NCT ID: NCT03562819 Org: User:
Start: 08/16/18 End: 06/07/19 Due: 06/07/20

A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone

Phase: N/A Priority: Normal
NCT ID: NCT00295633 Org: User:
Start: 03/31/06 End: 10/31/08 Due: 10/31/09

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

Phase: N/A Priority: Normal
NCT ID: NCT01226316 Org: User:
Start: 12/01/10 End: 12/03/24 Due: 12/03/25

Study of Durvalumab Following Radiation Therapy in Patients With Stage 3 Unresectable NSCLC Ineligible for Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04249362 Org: User:
Start: 11/26/20 End: 11/25/24 Due: 11/25/25

Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)

Phase: N/A Priority: Normal
NCT ID: NCT03775486 Org: User:
Start: 12/21/18 End: 09/26/25 Due: 09/26/26

Japanese Phase I Study of AZD2014 in Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02398747 Org: User:
Start: 03/17/15 End: 04/12/24 Due: 04/12/25

A Relative Bioavailability Study Measuring the Extent and Rate of Absorption of Different Tablet Formulations of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01221519 Org: User:
Start: 09/30/10 End: 01/31/11 Due: 01/31/12

A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients

Phase: N/A Priority: Normal
NCT ID: NCT01795339 Org: User:
Start: 03/31/13 End: 03/31/14 Due: 03/31/15

A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours.

Phase: N/A Priority: Normal
NCT ID: NCT03553108 Org: User:
Start: 05/16/18 End: 07/01/20 Due: 07/01/21

Study of the Broad Clinical Benefit for Seroquel XR With Flexible Dose as an add-on Therapy in the Treatment of Acute Bipolar Mania Patients With Partial Response to Current Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01128114 Org: User:
Start: 06/30/10 End: 03/31/11 Due: 03/31/12

Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study

Phase: N/A Priority: Normal
NCT ID: NCT02406677 Org: User:
Start: 06/05/15 End: 10/23/17 Due: 10/23/18

A Study of Fostamatinib in Subjects With Impaired Kidney Function

Phase: N/A Priority: Normal
NCT ID: NCT01245790 Org: User:
Start: 11/30/10 End: 06/30/11 Due: 06/30/12

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00254254 Org: User:
Start: 02/28/06 End: 02/28/07 Due: 02/28/08

Oral Mucosal Absorption of ICI176,334-1

Phase: N/A Priority: Normal
NCT ID: NCT01415791 Org: User:
Start: 08/31/11 End: 09/30/11 Due: 09/30/12

AZD8601 Study in CABG Patients

Phase: N/A Priority: Normal
NCT ID: NCT03370887 Org: User:
Start: 02/05/18 End: 06/30/21 Due: 06/30/22